Kamuran Karaman
Yüzüncü Yıl University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kamuran Karaman.
Journal of Maternal-fetal & Neonatal Medicine | 2015
Erdal Peker; Nihat Demir; Oğuz Tuncer; Lokman Üstyol; Ragıp Balahoroğlu; Sultan Kaba; Kamuran Karaman
Abstract The aim of the present study was to determine the serum levels of vitamin B12, folate, and homocysteine (Hcy) in mothers and their babies, and to assess the association between these levels and neural tube defect (NTD). The study group included 92 baby-mother pairs, where the babies had NTD, and the control group included 102 pairs, where the babies had no NTD, from May 2012 to May 2015. Plasma vitamin B12, folate, and Hcy levels of the babies and mothers were measured, and compared with each other. NTD was diagnosed in 2.6% of our babies. The vitamin B12 levels in the mothers and the babies in the study group were determined as 166.2 ± 63.7 pg/mL and 240.3 ± 120.3 pg/mL, and in the control group as 1 9 0 ± 80.2 pg/mL and 299.5 ± 151.4 pg/mL, respectively. There was a significant difference between the two groups in terms of both the mothers’ and the babies’ vitamin B12 levels (p = 0.024 and p = 0.003, respectively). The plasma folate levels of the mothers in the study group (5.2 ± 3 ng/mL) were significantly lower than control group (6.4 ± 4.3 ng/mL, p = 0.032).The plasma Hcy level of the mothers in the study group (9.3 ± 3.8 μmol/L) was significantly higher than the control group (7 ± 3.8 μmol/L, p < 0.001). High plasma Hcy levels and low plasma folate and vitamin B12 levels are risk factors for NTD. Our results show that the risk for NTD can be decreased by fortification of mothers-to-be, particularly in rural areas with folate and vitamin B12 deficiency, which would lower the plasma Hcy level.
Journal of Maternal-fetal & Neonatal Medicine | 2017
Nihat Demir; Murat Basaranoglu; Zübeyir Huyut; İbrahim Değer; Kamuran Karaman; M. Ramazan Şekeroğlu; Oğuz Tuncer
Abstract Objective: To determine levels of trace elements [copper (Cu), zinc (Zn), selenium (Se), and cobalt (Co)] and heavy metals [arsenic (As), mercury (Hg), lead (Pb), and cadmium (Cd)] in the plasma of mothers and infants and investigate the relationship between those levels and neural tube defects (NTD). Methods: A total of 100 neonates diagnosed with NTD and placed in the Neonatal Intensive Care Unit of Yuzuncu Yil University, Turkey between May 2013 and December 2016 comprised the study group. The control group consisted of 70 healthy neonates not diagnosed with NTD or any other congenital anomalies. For both the groups, mother and infant plasma levels of Cu, Zn, Co, Cd, Se, Hg, As, and Pb were measured and compared. Plasma levels of Cu, Zn, Co, Cd, Se, Hg, As, and Pb were measured and compared between two groups of mothers and infants. Findings: Mother and infant plasma levels of trace elements Zn and Se were determined to be significantly lower in the study group compared with the control group, while Cu levels were significant elevated in the study group (all p values < .05). Plasma levels of heavy metals As, Pb, and Cd were found to be significantly higher in the NTD control group (p < .05 for all). There was no association between maternal infection, maternal smoking status, history of miscarriage, or history of NTD with the development of NTD (p > .05). Differences in maternal age, birth weight, length of gestation, and infant gender for the two groups were also determined not to be statistically significant. Results: High plasma levels of heavy metals As, Pb, and Cd and trace element Cu were identified as risk factors for the development of NTD. At the same time, low plasma levels of trace elements Zn and Se were also found to be risk factors for NTD. However, no association between Hg and Co plasma levels and increased risk for the development of NTD was observed. This study, while being the most comprehensive case study to date investigating the relationship between heavy metals and trace element levels and increased risk of NTD, nonetheless highlights the need for further research in order to make definite statements regarding this relationship.
Cutaneous and Ocular Toxicology | 2016
Gülsüm İclal Bayhan; Mesut Garipardic; Kamuran Karaman; Sinan Akbayram
Abstract Voriconazole is a second-generation azole widely used for the prevention and treatment of fungal infection in leukemia patients. Voriconazole is considered the primary antifungal agent for invasive aspergillosis. We report a case of 16-year-old girl who developed visual disturbance and visual and auditory hallucinations after intravenous voriconazole treatment for invasive pulmonary aspergillosis. Due to the visual hallucinations and visual disturbance began acutely and shortly after the initiation of voriconazole, and no other cause could be determined, the symptoms were considered to be the side effects of voriconazole. Simultaneous development of visual side effects and hallucinations rarely have been reported before.
Journal of Pediatric Hematology Oncology | 2016
Kamuran Karaman; Sinan Akbayram; Seda Kar; Kaan Demiroren
We aimed to determine the prevalence of celiac disease (CD) in children with iron deficiency anemia (IDA) and compare the hematological variables of these children with those with IDA, but not with CD. A total of 250 patients aged 1 to 16 years with IDA were included. Upper gastrointestinal system endoscopy was recommended to the patients who were serologically positive for CD. According to the endoscopic biopsy results of 12 patients who have positive screening tests (57.1%), Marsh grade II histopathologic findings were detected in 1 (4.8%) and Marsh grade III histopathologic findings were detected in 11 (52%). The hemoglobin, hematocrit, iron, and ferritin levels were significantly lower in patients with CD with IDA, compared with those with IDA, but not with CD. According to Marsh classification, the percentage of Marsh grade IIIc was found to be higher than the other Marsh grades. As the Marsh grading increased, hemoglobin, hematocrit, serum iron, and ferritin levels decreased and tissue transglutaminase Ig A levels increased. Our results show that CD should be kept in mind as the underlying etiologic factor in patients with IDA.
Journal of Vaccines and Vaccination | 2014
Sinan Akbayram; Kamuran Karaman; Hatice Tuba Akbayram; Mesut Garipardic; Ahmet Faik Öner
Individual case reports and series have subsequently been published describing immune thrombocytopenia after vaccination [1,2]. Herein we report a case with acute immune thrombocytopenic purpura that were developed after DTaP-IPV-Hib combined vaccine (diphtheria/ tetanus/acellular pertussis, inactivated poliomyelitis, Haemophilus influenzae type b) and Pneumococcal Conjugate Vaccines (PCV).
Noise & Health | 2016
Nesrin Ceylan; Sultan Kaba; Kamuran Karaman; Metin Çeliker; Yildiray Basbugan; Nihat Demir
Hearing loss can occur in newborns exposed to high-level noise; noise exposure can cause more physiological stress and can lead to DNA damage. This study was designed to determine DNA damage in newborn rats exposed to sound at different concentrations. For this purpose, 28 newborn (3-6 days old) rats were divided into four groups of 7 rats in each group (Control and Groups of 40 decibel (dB), 70 dB, and 110 dB]. In the experimental groups, 40 dB, 70 dB, and 110 dB (7.5-15 kHz) of sound was applied to the experimental groups for 30 min a day for 7 days. DNA damage levels in the serums obtained from this study were determined by the enzyme-linked immunosorbent assay (ELISA) method. According to this, it was determined that DNA damage in the group exposed to 110 dB showed a statistically significant increase (P < 0.05) compared to the compared to the control, 40 dB, and 70 dB groups. Related to the subject, it was concluded that DNA damage may occur in newborns exposed to 110 dB or higher sound in neonatal units, wards, and home environments with newborn babies. Mothers should be warned about this situation and noise should be kept under 110 dB volume in the environments with the newborns.
Journal of Pediatric Hematology Oncology | 2016
Kamuran Karaman; Sinan Akbayram; Gülsüm İclal Bayhan; Mehmet Parlak; Hatice Tuba Akbayram; Hadi Geylan; Mesut Garipardic; Ahmet Faik Öner
The aim of the present study was to present the hematologic findings of 622 cases diagnosed with acute brucellosis. Medical records of children with brucellosis, admitted to Yuzuncu Yil University Hospital over a 6-year period, were analyzed retrospectively. Three hundred ninety-seven (63.8%) patients were male and 225 (36.2%) were female. The mean age was 11 years (range, 1 to 16 y). The mean hematologic values were as follows: hemoglobin 9.4 (3.4 to 17) g/dL, hematocrite 28% (12% to 50%), leukopenia 2.8 (1.1 to 33)×109/L, leukocytosis 13.7 (1.1 to 33)×109/L, and platelets 79 (3 to 972)×109/L. An overall 28.6% of patients were found to have anemia, alone or in combination with leukopenia or thrombocytopenia. Sixteen percent of patients had thrombocytopenia, 13.9% had leukopenia, 7.7% had pancytopenia, and 4% had both leukopenia and thrombocytopenia. Hematologic complications such as anemia, thrombocytopenia, and leukopenia are more frequently seen in acute brucellosis cases. However, acute brucellosis should also be considered in the differential diagnosis in the presence of other hematologic abnormalities such as severe thrombocytopenia, bicytopenia, and pancytopenia.
Turk Pediatri Arsivi-turkish Archives of Pediatrics | 2015
Kamuran Karaman; Sinan Akbayram; Mesut Garipardic; Ahmet Fayik Öner
AIM Hemophilia A is a rare inherited bleeding disorder resulting from factor VIII deficiency and is a group of diseases characterized by intra-articular and intramuscular bleeding. In this study, we aimed to retrospectively evaluate the treatment outcomes, demographic and clinical characteristics of our patients who were treated and followed up for last 17 years in our pediatric hematology unit with a diagnosis of Hemophilia A. MATERIAL AND METHODS The medical records of 83 patients who were diagnosed with Hemophilia A and followed up between 1997 and 2014 in our hospitals pediatric hematology clinic were reviewed retrospectively. The demographic data, prophylaxis state, development of inhibitors and clinical characteristics of the patients were evaluated. RESULTS When the complaints at presentation were examined, it was found that 27 (32%) patients had hemarthrosis, 24 (29%) patients had ecchymosis and hematoma, 13 (16%) patients had prolonged bleeding after trauma or cut, 10 (12%) patients had gingival, mouth or nose bleeding, 4 (5%) patients had prolonged bleeding after circumcision, 4 (5%) patients had gastrointestinal bleeding, 1 (1%) patient had hematuria. Fifty (60%) patients were considered severe hemophilia A, 20 (24%) patients were considered moderate hemophilia A and 13 (16%) patients were considered mild hemophilia A according to factor activity. Among severe hemophilia A patients, primary prophylaxis was being administered in 2 (2%) patients and secondary prophylaxis was being administered in 40 (48%) patients. Inhibitor positivity was found in 8 (10%) of these patients. It is found that hemophilic artropathy developed in 17 patients and 8 of these 17 patients had undergone radioisotope synovectomy. CONCLUSIONS Treatment of severe bleeding in hemophilia A patients should be performed in hospital and the presence of inhibitor must be investigated in cases of uncontrolled bleeding where adequate doses of factor concentrates have been administered for treatment. In order to decrease the development of inhibitor, prophlaxis should be suggested to patients rather than repetetive treatment when bleeding occurs. The radioactive synovectomy should not be overlooked in countries like ours in which factors can not be used adequately.
British journal of medicine and medical research | 2015
Erbil Karaman; Kamuran Karaman
Objective: To report a case of pregnant woman with low thrombocyte count which in fact has spurious thrombocytopenia. Methods: A 40-week pregnant woman was admitted to our obstetric clinic with complaint and signs of active labour. She was hospitalized and followed for the vaginal birth. Results: On laboratory examination, the low platelet (Plt) count as 42 x 103/mm was measured by using blood samples with ethylenediaminetetraacetic acid (EDTA). Patient had no history for echymosis, bleeding disorders and bruising. She underwent a differential diagnosis for thrombocytopenia in term pregnancy for preeclampsia, HELLP syndrome, acute fatty liver disease or immune thrombocytopenic purpura and no pathology was found. The peripheral blood smear showed platelet (plt) clustering with normal count as 181 x 103/mm. She diagnosed as pseudothrombocytopenia. The patient delivered a healthy baby with vaginal way and had no bleeding complication in pospartum period. Conclusion: Thrombocytopenia in pregnancy is a challenging and important issue for obstetrician. Case Report Erbil and Kamuran; BJMMR, 6(12): 1196-1200, 2015; Article no.BJMMR.2015.299 1197 We aimed to point out that low Plt count doesn’t indicate always a serious disease in term pregnancy. Pseudothrombocytopenia should be kept in mind which may cause unnecessary laboratory examination and treatments.
Van Medical Journal | 2018
Hadi Geylan; Mecnun Çetin; Kamuran Karaman
Vinkristin; lenfoma ve lösemi gibi bir çok malignitenin kemoterapi protokolünde sıklıkla kullanılan hücre siklusuna oldukça spesifik bir vinka alkaloididir. Vinkristin nörotoksisitesi; periferal nöropati, otonomik nöropati, kranial sinir paralizileri ve ensefalopati olmak üzere dört farklı şekilde karşımıza çıkabilmektedir. Bu yan etkiler vinkristin kullanımında sınırlayıcı faktörler olarak rol oynar (1). Hodgkin lenfoma tanısıyla vinkristin tedavisi sonrası parsiyel intestinal obstrüksiyon gelişen ve medikal olarak tedavi edilen 13 yaşındaki bir kız olguyu sunuyoruz.